Compare GSK plc (GSK) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Modine Manufacturing Company — how do they compare? GSK plc trades at $52.68 (market cap $101.34B), while Modine Manufacturing Company trades at $225.54 (market cap $12.32B). The key difference: GSK plc is far larger — about 8.2× Modine Manufacturing Company's market cap, and GSK plc pays a 3.49% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.
| GSK | MOD | |
|---|---|---|
Market Cap | $101.34B | $12.32B |
Sector | Health | Technology |
52-Week High | $61.18 | $306.89 |
52-Week Low | $36.20 | $91.30 |
Enterprise Value | $121.95B | $12.68B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Modine (MOD) trades at $230.04, up 0.2% with a bearish technical signal despite strong analyst consensus. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 results pending. Financials show solid revenue growth to $2.58B in 2025 but declining profit margins. The stock faces technical headwinds with key support at $225 and resistance at $235.
Modine presents a mixed outlook with strong analyst support (76.9% buy ratings) and a $328.80 price target suggesting 43% upside. However, declining profit margins and bearish technical indicators create near-term uncertainty. The data center business expansion offers growth potential, but execution risks and competitive pressures remain key challenges for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
